NDC 81561-413

ERWINASE

Asparaginase

ERWINASE is a Intramuscular; Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Porton Biopharma Limited. The primary component is Asparaginase Erwinia Chrysanthemi.

• Product ID: 81561-413_10bba7af-957c-4cc6-ba44-5569fca4f885
• NDC: 81561-413
• Product Type: Human Prescription Drug
• Proprietary Name: ERWINASE
• Generic Name: Asparaginase
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAMUSCULAR; INTRAVENOUS
• Marketing Start Date: 2021-06-01
• Marketing Category: UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE /
• Labeler Name: Porton Biopharma Limited
• Substance Name: ASPARAGINASE ERWINIA CHRYSANTHEMI
• Active Ingredient Strength: 10000 [iU]/mL
• Pharm Classes: Asparaginase [CS],Asparagine-specific Enzyme [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 81561-413-05

5 VIAL, GLASS in 1 CARTON (81561-413-05) > 1 mL in 1 VIAL, GLASS (81561-413-01)

• Marketing Start Date: 2021-06-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "ERWINASE" or generic name "Asparaginase"

NDC	Brand Name	Generic Name
81561-413	ERWINASE	asparaginase
57902-249	ERWINAZE	Asparaginase